AI-generated summary
In a mouse model of spinal cord injury, the authors report that 810 nm photobiomodulation restored motor function and reduced chondroitin sulfate proteoglycan expression in the injured cord. They also report that versican was among the most changed molecules and that photobiomodulation reduced versican expression in inflammatory astrocytes cultured in vitro, with pathway involvement suggested by inhibitor experiments. These findings are preclinical, and the authors suggest Smad3/Sox9 and MAPK/Sox9 pathways may mediate the effects.
- Who or what was studied
- Mice with spinal cord injury (T9 clamping model) and cultured primary astrocytes
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study is preclinical, using mice and cultured cells, and the specific mechanism is suggested rather than confirmed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power density (irradiance)
- 50 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.